China Approves World's First Minimally Invasive Brain-Computer Interface
China has approved a minimally invasive brain-computer interface (BCI) device for commercial use, developed by Neuracle Medical Technology. This breakthrough technology enables people with spinal cord injuries to regain hand function. The approval marks a significant milestone in the BCI field, which is gaining interest globally due to its potential applications in healthcare and technology.
Key points
- China's government has approved the world's first minimally invasive BCI device for commercial use, developed by Neuracle Medical Technology.
- The device enables people with spinal cord injuries to regain hand function, marking a significant milestone in the BCI field.
- The Chinese government has included BCI as a strategic 'future industry' in its latest Five-Year Plan.
- The technology is raising the stakes in the U.S.-China rivalry, with companies like StairMed and NeuroXess pushing ahead with implant-based BCI solutions.
- The approval of the minimally invasive device is expected to boost interest in the BCI field, with potential applications in healthcare and technology.
China has made a significant breakthrough in the brain-computer interface (BCI) field with the approval of the world's first minimally invasive BCI device for commercial use. Developed by Neuracle Medical Technology, the device enables people with spinal cord injuries to regain hand function. This development marks a significant milestone in the BCI field, which is gaining interest globally due to its potential applications in healthcare and technology.
The Chinese government has included BCI as a strategic 'future industry' in its latest Five-Year Plan, indicating the country's commitment to developing this technology. The approval of the minimally invasive device is expected to boost interest in the BCI field, with potential applications in healthcare and technology.
The BCI field is a rapidly evolving area of research, with companies like StairMed and NeuroXess pushing ahead with implant-based BCI solutions. However, the approval of the minimally invasive device is expected to provide an alternative solution for those who do not want to undergo invasive surgery.
The technology is raising the stakes in the U.S.-China rivalry, with both countries competing to develop and commercialize BCI solutions. The approval of the minimally invasive device is a significant step forward for China, and it is expected to have a positive impact on the country's healthcare and technology sectors.
Sources
The WireByte editorial team synthesises technology news from multiple primary sources, verifies the facts, and links every source. Articles are produced with AI assistance and reviewed under our editorial policy.